The binding energies of the prepared molecules and their molecular interactions with the active site of the target enzyme.
| 2D structure | B.E.a (kcal mol−1) | Docked complex (amino acid–ligand) interactions | Distance (Å) | |
|---|---|---|---|---|
| 2a |
|
−7.0 | H-Bond | |
| Glu226:OE2—compound 2a | 2.40 | |||
| 2b |
|
−7.1 | H-Bond | |
| Lys224:N—compound 2b | 3.00 | |||
| Tyr235:N—compound 2b | 2.96 | |||
| Arene–cation | ||||
| Arg206:NH2—compound 2b | 5.13 | |||
| 3 |
|
−9.1 | Arene–arene | |
| Phe43—compound 3 | 5.15 | |||
| Arene–cation | ||||
| Val98:CG2—compound 3 | 3.49 | |||
| 4 |
|
−8.1 | H-Bond | |
| Tyr126:OH—compound 4 | 2.96 | |||
| 5 |
|
−9.6 | H-Bond | |
| Lys84:NZ—compound 5 | 2.89 | |||
| Gln207:N—compound 5 | 2.98 | |||
| Lys224:N—compound 5 | 3.00 | |||
| Tyr235:N—compound 5 | 2.96 | |||
| Arene–cation | ||||
| Arg206:NH1—compound 5 | 4.42 | |||
| Arg206:NH2—compound 5 | 5.98 | |||
| 6a |
|
−10.4 | H-Bond | |
| Tyr29:OH—compound 6a | 2.98 | |||
| Tyr29:OH—compound 6a | 3.01 | |||
| Ala130:N—compound 6a | 2.98 | |||
| 6b |
|
−10.0 | H-Bond | |
| Ala130:N—compound 6b | 2.95 | |||
| 7 |
|
−6.3 | H-Bond | |
| Asn80:ND2—compound 7 | 3.08 | |||
| 8 |
|
−6.9 | H-Bond | |
| His392:ND1—compound 8 | 2.96 | |||
| Ile391:O—compound 8 | 2.34 | |||
| Standard drug |
|
−7.9 | H-Bond | |
| Tyr393:N—standard drug | 3.18 | |||
| Glu388:OE1—standard drug | 2.40 | |||
| Arene–arene | ||||
| Tyr393—standard drug | 4.55 |
B.E. binding energy.